Teleflex Inc (TFX) Stock Price, Quote & News

Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also of...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 610-225-6800

Website: www.teleflex.com

Address:

550 East Swedesford Road, Suite 400, Wayne, United States

SuperGreenToday Oct. 3 at 8:20 PM

$TFX Share Price: $130.95 Contract Selected: Jan 16, 2026 $130 Calls Buy Zone: $9.43 – $11.65 Target Zone: $17.44 – $21.31 Potential Upside: 75% ROI Time to Expiration: 104 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

JackDarwin Sep. 27 at 10:45 AM

$TFX Bullish Harami Candlestick Pattern.

0 · Reply

ZacksResearch Aug. 21 at 2:50 PM

$TFX jumps 3.7% following new product launch! 🚀 Teleflex's Barrigel rectal spacer gets the green light in Japan, marking a key milestone in its global push. With a solid market sentiment boost and an impressive 11.3% earnings yield compared to the industry’s -5.2%, TFX is well-positioned against industry headwinds. See what makes the investment case strong for TFX 👉 https://www.zacks.com/stock/news/2740846/teleflex-stock-gains-following-barrigels-launch-in-japan?cid=sm-stocktwits-2-2740846-body-8798&ADID=SYND_STOCKTWITS_TWEET_2_2740846_BODY_8798

0 · Reply

ZacksResearch Aug. 21 at 1:50 PM

$TFX breaks out on global expansion move 🌏 Shares popped 3.7% after the launch of Barrigel in Japan — a clear milestone in the company’s worldwide growth strategy. Full breakdown here 👉 https://www.zacks.com/stock/news/2740846/teleflex-stock-gains-following-barrigels-launch-in-japan?cid=sm-stocktwits-2-2740846-teaser-8797&ADID=SYND_STOCKTWITS_TWEET_2_2740846_TEASER_8797

0 · Reply

MapTechnicalForecasting Aug. 20 at 3:01 AM

$TFX starting to look tempting 🤔

0 · Reply

inelegantinvest Aug. 19 at 10:21 PM

Teleflex is charting a new course—splitting into two focused medtech companies by mid-2026. RemainCo keeps vascular, interventional & surgical lines. NewCo inherits urology, acute care & OEM design/manufacturing. Tax-free spin, double-digit EPS growth expected. Dive deeper ⤵ https://www.stockspinoffs.com/2025/08/19/teleflex-spinoff-of-urology-acute-care-and-oem-businesses-expected-in-mid-2026/ $TFX #teleflex

0 · Reply

NeveREn0ugH Aug. 12 at 2:43 PM

$TFX accumulation

0 · Reply

NeveREn0ugH Aug. 6 at 6:39 PM

$TFX whats up w this!?

1 · Reply

scientificway Aug. 4 at 7:25 PM

$TFX My recomandation MDXG, huge rev, eps, guidance up. , guidance is so good, how much after a year

0 · Reply

IN0V8 Aug. 4 at 3:45 PM

$TFX Truist Securities raises target price to $128 from $123

0 · Reply

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

Sep 11, 2025, 6:30 AM EDT - 6 weeks ago

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients

Sep 10, 2025, 12:21 PM EDT - 6 weeks ago

Teleflex Incorporated (TFX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 26, 2025, 6:30 AM EDT - 2 months ago

Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 19, 2025, 6:30 AM EDT - 2 months ago

Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy

Jul 31, 2025, 7:14 PM EDT - 3 months ago

Teleflex Incorporated (TFX) Q2 2025 Earnings Conference Call Transcript

Jul 31, 2025, 6:45 AM EDT - 3 months ago

Teleflex Announces Quarterly Dividend

Jul 31, 2025, 6:30 AM EDT - 3 months ago

Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook

Jul 25, 2025, 11:15 AM EDT - 3 months ago

Chest Drainage Catheters Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Leading Players - BD, Teleflex, Cook, ICU Medical, and Redax

Jul 17, 2025, 6:30 AM EDT - 3 months ago

Teleflex Announces Second Quarter 2025 Earnings Conference Call Information

Jul 1, 2025, 6:30 AM EDT - 4 months ago

Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business

Jun 12, 2025, 6:30 AM EDT - 4 months ago

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

Jun 11, 2025, 6:30 AM EDT - 4 months ago

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month

May 19, 2025, 6:30 AM EDT - 5 months ago

Teleflex Publishes 2024 Global Impact Report

May 15, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Shareholders to Learn More About the Investigation

May 15, 2025, 6:30 AM EDT - 5 months ago

Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting

May 14, 2025, 10:00 AM EDT - 5 months ago

Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

May 13, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Shareholders to Inquire about Securities Investigation

May 13, 2025, 6:30 AM EDT - 5 months ago

New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy

May 12, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Shareholders to Connect

May 11, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Investors to Connect

May 9, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Stockholders to Inquire about Securities Investigation

May 8, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Investors to Learn More About the Investigation

May 7, 2025, 10:00 AM EDT - 6 months ago

Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 7, 2025, 9:31 AM EDT - 6 months ago

TFX Investors Have Opportunity to Join Teleflex Incorporated Fraud Investigation with the Schall Law Firm

May 5, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Stockholders to Learn More About the Investigation

May 4, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Investors to Inquire about Securities Investigation

May 2, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teleflex Incorporated (TFX) And Encourages Investors to Reach Out

May 1, 2025, 3:13 PM EDT - 6 months ago

Teleflex Incorporated (TFX) Q1 2025 Earnings Call Transcript

May 1, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teleflex Incorporated (TFX) And Encourages Stockholders to Reach Out

May 1, 2025, 6:30 AM EDT - 6 months ago

Teleflex Reports First Quarter Financial Results and Full Year 2025 Outlook

Apr 30, 2025, 10:30 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Stockholders to Connect

Apr 30, 2025, 6:45 AM EDT - 6 months ago

Teleflex to Present at the BofA Securities 2025 Health Care Conference

Apr 30, 2025, 6:30 AM EDT - 6 months ago

Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device

Apr 24, 2025, 6:30 AM EDT - 6 months ago

Teleflex Announces Clinical and Real-World Evidence Studies and Physician Educational Opportunities to Be Highlighted at the 2025 American Urological Association (AUA) Annual Meeting

Apr 17, 2025, 6:30 AM EDT - 6 months ago

Teleflex Announces First Quarter 2025 Earnings Conference Call Information

Apr 1, 2025, 6:30 AM EDT - 7 months ago

Teleflex Receives FDA 510(k) Clearance of the AC3 Range™ Intra-Aortic Balloon Pump (IABP)

Mar 27, 2025, 6:30 AM EDT - 7 months ago

Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference

Mar 25, 2025, 6:30 AM EDT - 7 months ago

Teleflex Announces Updated Clinical Study Data Presented at the European Association of Urology (EAU) Congress

Mar 11, 2025, 7:05 AM EDT - 8 months ago

AcuityMD Signs 300th MedTech Customer, Teleflex

Mar 7, 2025, 6:19 PM EST - 8 months ago

DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

ALK AMBC ATI BBWI BWA CC CE

SuperGreenToday Oct. 3 at 8:20 PM

0 · Reply

JackDarwin Sep. 27 at 10:45 AM

$TFX Bullish Harami Candlestick Pattern.

0 · Reply

ZacksResearch Aug. 21 at 2:50 PM

0 · Reply

ZacksResearch Aug. 21 at 1:50 PM

0 · Reply

MapTechnicalForecasting Aug. 20 at 3:01 AM

$TFX starting to look tempting 🤔

0 · Reply

inelegantinvest Aug. 19 at 10:21 PM

0 · Reply

NeveREn0ugH Aug. 12 at 2:43 PM

$TFX accumulation

0 · Reply

NeveREn0ugH Aug. 6 at 6:39 PM

$TFX whats up w this!?

1 · Reply

scientificway Aug. 4 at 7:25 PM

$TFX My recomandation MDXG, huge rev, eps, guidance up. , guidance is so good, how much after a year

0 · Reply

IN0V8 Aug. 4 at 3:45 PM

$TFX Truist Securities raises target price to $128 from $123

0 · Reply

scientificway Aug. 3 at 4:25 AM

$TFX check MDXG out, last chance below 7.2, explosion due to rev. eps surprise

0 · Reply

JarvisFlow Aug. 1 at 4:20 PM

RBC Capital updates rating for Teleflex ( $TFX ) to Sector Perform, target set at 130 → 135.

0 · Reply

REDBEAR Jul. 31 at 5:28 PM

$TFX LFG

1 · Reply

BigSqueezeComing Jul. 31 at 10:59 AM

$TFX pt 136

0 · Reply

BigSqueezeComing Jul. 31 at 10:56 AM

$TFX Teleflex Announces Quarterly Dividend By Teleflex Incorporated | July 31, 2025, 6:45 AM

0 · Reply

DonCorleone77 Jul. 31 at 10:45 AM

$TFX Teleflex reports Q2 adjusted EPS $3.73, consensus $3.37 -- Q2 revenue $780.9M, consensus $771.53M. -- Raises FY25 adjusted EPS view to $13.90-$14.30 from $13.20-$13.60, consensus $13.39.

0 · Reply

REDBEAR Jul. 17 at 5:35 PM

$TFX ok, here we go. trade like clockwork. don't deviate, don't hesistate. when it gives it to you, execute. so i will, starter.

0 · Reply

JarvisFlow Jul. 15 at 3:10 PM

RBC Capital has updated their rating for Teleflex ( $TFX ) to Sector Perform with a price target of 130.

0 · Reply

NVDAMillionaire Jul. 9 at 1:49 PM

$TFX Outstanding article that hits the mark on TFX's current state. So if you want to refresh your TFX insights or learn about TFX from scratch, this is a must read. https://beyondspx.com/article/teleflex-strategic-transformation-amidst-headwinds-points-to-a-reshaped-future-nyse-tfx

1 · Reply

TradeInYourJob Jul. 6 at 11:50 AM

$TFX no position, needs to get back through the $135 ish area before retesting the breakdown point.

0 · Reply

ZacksResearch Jul. 3 at 1:50 PM

$TFX expands with a strategic acquisition! 🚀 Teleflex just wrapped up its BIOTRONIK Vascular Intervention business purchase, boosting its interventional access line and global presence. Expect this move to position TFX for participation in resorbable scaffold technologies and positively impact market sentiment. Full details on TFX's growth prospects here 👉 https://www.zacks.com/commentary/2561632/teleflex-acquires-biotroniks-vascular-intervention-business-stock-up?cid=sm-stocktwits-2-2561632-body-708&ADID=SYND_STOCKTWITS_TWEET_2_2561632_BODY_708

0 · Reply

ZacksResearch Jul. 3 at 12:16 PM

$TFX just made a bold move — and Wall Street liked it 📈 Shares popped 2.9% after acquiring BIOTRONIK's vascular unit, strengthening its cath lab footprint and future innovation pipeline. See what this could mean for TFX’s growth story 👉 https://www.zacks.com/stock/news/2561632/teleflex-acquires-biotroniks-vascular-intervention-business-stock-up?cid=sm-stocktwits-2-2561632-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2561632_TEASER

0 · Reply

Market Cap	5.85B
Revenue (ttm)	3.05B
Net Income (ttm)	69.68M
EPS (ttm)	N/A
PE Ratio	9.47
Forward PE	9.46
Profit Margin	2.29%
Debt to Equity Ratio	0.45

Volume	289,500
Avg Vol	562,340
Day's Range	N/A - N/A
Shares Out	44.19M
Stochastic %K	77%
Beta	1.05
Analysts	Sell
Price Target	$132.62